Protagonist Therapeutics Inc (PTGX)
R&D Expenses
$42.06M
Quarterly · Period ending: · USD
PTGX R&D Expenses
Latest reported$42.06Mperiod ending
Latest reported$42.06Mperiod ending
PTGX Quarterly R&D Expenses ($2.18M → $42.06M)
Quarterly R&D Expenses
High-resolution chart · PNG
PTGX r&d expenses history
Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 42,061,000 | |
| 46,739,000 | |
| 46,358,000 | |
| 40,003,000 | |
| 37,036,000 | |
| 35,893,000 | |
| 34,904,000 | |
| 35,970,000 | |
| 33,520,000 | |
| 33,734,000 | |
| 28,899,000 | |
| 30,664,000 | |
| 33,182,000 | |
| 27,416,000 | |
| 29,884,000 | |
| 25,402,000 | |
| 34,611,000 | |
| 36,318,000 | |
| 39,273,000 | |
| 36,956,000 | |
| 27,417,000 | |
| 25,073,000 | |
| 20,126,000 | |
| 15,995,000 | |
| 20,257,000 | |
| 18,768,000 | |
| 15,911,000 | |
| 17,293,000 | |
| 19,355,000 | |
| 12,444,000 | |
| 14,248,000 | |
| 12,145,000 | |
| 17,735,000 | |
| 15,368,000 | |
| 11,724,000 | |
| 11,168,000 | |
| 12,007,000 | |
| 11,282,000 | |
| 8,823,000 | |
| 5,561,000 | |
| 5,696,000 | |
| 5,625,000 | |
| 4,193,000 | |
| 3,158,000 | |
| 2,297,000 | |
| 2,183,000 |